The outcomes of all trials are of upmost importance to all holders and MSB, however we also must realise that the world has changed regarding COVID-related work priorities; this may impact upon other important work that was being conducted. I don't have a problem with this, the company does not unlimited resources to devote to each project.
To add further complication, politics may become involved with some of MSB's COVID-related work. IF politics are involved this will put a strain on resources and necessitate a short-term adjustment of priorities.
I'm sure we'll hear about the CHF trial outcomes when MSB is required to inform the market.
MSB Price at posting:
$3.81 Sentiment: Buy Disclosure: Held
(20min delay)